Study title: Multicenter, open label, phase 3 study on safety, clinical utility, PK, pediatric patients with chronic pain, 2-12 yrs
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Anesthesia and Analgesia [E03] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: FENTANYL | |||||
| ATC code: | |||||
| Document link: LMD170470_Interventional_Fentanyl.xls | |||||
| Document date: 2011-09-21 | |||||
| Study number: FEN-INT-24 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |